Abivax ABVX
NASDAQ ABVX
$90.23 -3.26 (-3.49%)
At close: Oct 22, 2026 · 4:00 PM EDT

Abivax (ABVX) Gains from Investment Securities (2024 - 2025)

Updated

Analysis

Abivax (ABVX) Gains from Investment Securities (2024 - 2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,144.36 Bn 1,112.95 Bn 19.71 Bn
2 Johnson & Johnson 635.36 Bn 555.22 Bn 17.30 Bn
3 AbbVie 502.79 Bn 475.90 Bn 12.70 Bn
4 Merck 356.08 Bn 310.46 Bn 12.21 Bn
5 Novartis Ag 300.87 Bn 264.86 Bn 11.24 Bn
6 Astrazeneca 264.31 Bn 237.99 Bn 12.86 Bn
7 Amgen 239.07 Bn 194.47 Bn 7.24 Bn
8 Gilead Sciences 194.50 Bn 168.70 Bn 6.22 Bn
9 Pfizer 171.00 Bn 117.64 Bn 10.94 Bn
10 Abivax 6.15 Bn 3.79 Bn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 -73.95 Mn
Jun 30, 2025 2.28 Mn
Mar 31, 2025 -1.14 Mn
Dec 31, 2024 293,863.74
Sep 30, 2024 -287,733.51
Jun 30, 2024 -1.95 Mn
Mar 31, 2024 417,162.92
API Access

Abivax Gains from Investment Securities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-investment-securities&ticker=ABVX&period=max&api_key=YOUR_API_KEY